Clinical Translational Science Institute VP of Investor Relations Salaries in Wilmington, DE | Comparably
CTSI provides infrastructure, services, and training to support clinical and translational research. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
90

Clinical Translational Science Institute VP of Investor Relations Salaries in Wilmington, DE

$77k
$120k
$129k
$225k
N/A
Average Compensation

VP of Investor Relations Salaries at Clinical Translational Science Institute

In Wilmington, DE, VPs of Investor Relations earn $82,002 less than Editors.

Director of PR
$158k*
Editor
$82k*
* estimated salary

Compensation at Clinical Translational Science Institute by Department

In Wilmington, DE, The Communications Department averages $10,940 more than the Engineering Department, and $801 less than the Product Department

Product
$130,860 Avg. total comp.
+$801
Communications
$130,059 Avg. total comp.
Engineering
$119,119 Avg. total comp.
-$11k

How VPs of Investor Relations at Clinical Translational Science Institute Rate Their Compensation

The majority of VPs of Investor Relations at Clinical Translational Science Institute believe they're compensated fairly. 100% of VPs of Investor Relations at Clinical Translational Science Institute say they receive annual bonuses. See more compensation ratings at Clinical Translational Science Institute

×
Rate your company